|
Real-time Estimate
Cboe BZX
21:56:22 28/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 6.995 USD | +5.19% |
|
+9.31% | +122.81% |
| 10-25 | Agenus Inc. Reports Early Phase 2 Results From dMMR Colon Cancer Cohort Of NEOASIS Study | CI |
| 10-08 | Agenus Gets Armenia Approval for Botensilimab-Balstilimab Combination | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
- Stock Market
- Stocks
- AGEN Stock
- Charts Agenus Inc.
- Total Return chart
Select your edition
All financial news and data tailored to specific country editions
